×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Loss of succinyl-CoA synthase ADP-forming β subunit disrupts mtDNA stability and mitochondrial dynamics in neurons.
28769029
2017
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion.
27913098
2017
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
26475597
2016
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Novel mutation in SUCLA2 identified on sequencing analysis.
26952923
2016
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Proteomics. Tissue-based map of the human proteome.
25613900
2015
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
MMDB and VAST+: tracking structural similarities between macromolecular complexes.
24319143
2014
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
[SUCLA2-related encephalomyopathic mitochondrial DNA depletion syndrome: a case report and review of literature].
25582465
2014
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
The novel mutation p.Asp251Asn in the β-subunit of succinate-CoA ligase causes encephalomyopathy and elevated succinylcarnitine.
23759946
2013
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.
23385875
2013
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
A novel homozygous mutation in SUCLA2 gene identified by exome sequencing.
23010432
2012
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.
17287286
2007
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
17301081
2007
×
Entrez Id:
8803
Gene Symbol:
SUCLA2
SUCLA2
0.300
Biomarker
disease
CLINGEN
Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion.
15877282
2005